Shares

15 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 28, 2024

BUY
$43.02 - $53.69 $636,351 - $794,182
14,792 New
14,792 $691,000
Q2 2023

Aug 21, 2023

SELL
$37.35 - $52.15 $484,653 - $676,698
-12,976 Reduced 24.12%
40,822 $1.88 Million
Q1 2023

May 11, 2023

SELL
$36.99 - $48.71 $188,279 - $247,933
-5,090 Reduced 8.64%
53,798 $2.16 Million
Q4 2022

Feb 22, 2023

SELL
$33.72 - $46.33 $445,812 - $612,528
-13,221 Reduced 18.33%
58,888 $2.73 Million
Q3 2022

Nov 22, 2022

SELL
$39.96 - $66.14 $13,146 - $21,760
-329 Reduced 0.45%
72,109 $2.99 Million
Q1 2022

Jun 07, 2022

BUY
$62.2 - $84.4 $1.11 Million - $1.51 Million
17,857 Added 32.72%
72,438 $5.26 Million
Q4 2021

Feb 08, 2022

BUY
$73.71 - $87.86 $494,741 - $589,716
6,712 Added 14.02%
54,581 $4.59 Million
Q3 2021

Nov 10, 2021

BUY
$77.92 - $102.4 $3.73 Million - $4.9 Million
47,869 New
47,869 $4.32 Million
Q3 2019

Nov 07, 2019

SELL
$42.5 - $63.11 $2.2 Million - $3.27 Million
-51,877 Closed
0 $0
Q2 2019

Oct 03, 2019

BUY
$54.93 - $74.36 $119,198 - $161,361
2,170 Added 4.37%
51,877 $3.29 Million
Q4 2018

Feb 14, 2019

BUY
$38.89 - $77.3 $390,377 - $775,937
10,038 Added 25.3%
49,707 $2.16 Million
Q3 2018

Nov 08, 2018

SELL
$71.81 - $90.15 $886,997 - $1.11 Million
-12,352 Reduced 23.74%
39,669 $3.03 Million
Q2 2018

Aug 13, 2018

SELL
$48.54 - $85.31 $52,180 - $91,708
-1,075 Reduced 2.02%
52,021 $4 Million
Q1 2018

May 11, 2018

BUY
$44.33 - $58.52 $25,445 - $33,590
574 Added 1.09%
53,096 $2.71 Million
Q4 2017

Feb 14, 2018

BUY
$43.54 - $57.32 $2.29 Million - $3.01 Million
52,522
52,522 $2.44 Million

Others Institutions Holding RARE

About Ultragenyx Pharmaceutical Inc.


  • Ticker RARE
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 70,036,896
  • Market Cap $3.13B
  • Description
  • Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in North America, Europe, and internationally. Its biologic products include Crysvita (burosumab), an antibody targeting fibroblast...
More about RARE
Track This Portfolio

Track Teachers Retirement System Of The State Of Kentucky Portfolio

Follow Teachers Retirement System Of The State Of Kentucky and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Teachers Retirement System Of The State Of Kentucky, based on Form 13F filings with the SEC.

News

Stay updated on Teachers Retirement System Of The State Of Kentucky with notifications on news.